UroGen Pharma Ltd. (URGN)

NASDAQ: URGN · Real-Time Price · USD

18.59

+0.11 (0.60%)

Mar 19, 2026, 4:00 PM EDT - Market closed

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Biotechnology	109.79M	90.40M	82.71M	64.36M	48.04M
Biotechnology Growth	21.45%	9.29%	28.52%	33.96%	307.17%
Total	109.79M	90.40M	82.71M	64.36M	48.04M
Total Growth	21.45%	9.29%	28.52%	33.96%	307.17%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Israel	109.79M	90.40M	82.71M	64.36M	48.04M
Israel Growth	21.45%	9.29%	28.52%	33.96%	307.17%
Total	109.79M	90.40M	82.71M	64.36M	48.04M
Total Growth	21.45%	9.29%	28.52%	33.96%	307.17%

Source: S&P Global Market Intelligence.